- 期刊
中藥淨冠方在COVID-19疫情間之使用感受與滿意度調查
An Investigation Of Perception And Satisfaction Toward Using The Traditional Chinese Medicine Jing Guan Fang During The COVID-19 Pandemic
摘要
隨著新型冠狀病毒肺炎（COVID-19）的全球大流行，臺灣疫苗一度短缺且疫情不穩定的情況下，有豐富治療傳染性疫病的中醫藥可做為臨床治療之選擇，研製「淨冠方」用於時疫初期輕症或接觸者。本研究之目的係探討使用淨冠方對於預防以及高風險或已確診族群之感受與滿意度，藉以提供新冠肺炎疫情期間對預防及輕症者之中醫藥選擇。本研究屬橫斷性研究，以自填結構式問卷對淨冠方之使用者收集資料，共469份問卷納入研究，預防使用組與高風險或已確診組分別為380人及89人。研究結果顯示，較多淨冠方的使用者認為使用後能緩解疲勞、改善情緒緊繃，對高風險或已確診組則另較能緩解喉嚨痛、頭痛、咳嗽等症狀。淨冠方之使用者皆對其能增強抵抗、減少病症者感到認同，並皆有相當高的滿意度（分別為7.13±2.34與8.89±1.58），其中高風險或已確診組的滿意程度顯著較高（P＜0.001）。藉由本研究希望能提供淨冠方做為中醫用藥之參考，建議未來可增加更多臨床實證研究，考量新冠肺炎之中西藥合併治療，以提升治療之品質。
並列摘要
During the pandemic of novel coronavirus pneumonia (COVID-19), scientists were looking for or developing drugs and vaccines to blockade the spreading of the virus worldwide. In Taiwan, the vaccines for COVID-19 were insufficient. Hence, the epidemic outbreak in the first half of 2021. Traditional Chinese medicine Jing-Guan-Fang (JGF) was formulated to relieve patients with ailments and for contact confirmed cases to prevent infection. Our objectives were to explore the feeling and satisfaction among JGF users and compare the users for prevention with those at a high risk of being infected or the confirmed cases. This was a cross-sectional study. A structural questionnaire was adopted. The study enrolled 469 samples, including 380 users for prevention and 89 users who were high-risk infected or confirmed cases. The results showed that many users felt the symptoms of fatigue and anxiety were relieved after using JGF. In particular, the users who were high-risk infected or confirmed cases felt JGF could alleviate throat ache, headache, and cough. Most users agreed that JGF could enhance disease resistance and relieve illness. Additionally, most users were satisfied with JGF, the satisfaction score were 7.13±2.34 and 8.89±1.58 respectively. The score of the users who were high-risk infected or confirmed cases was significantly higher than the users for prevention(P＜0.001). According to the analysis of the results, we demonstrated several benefits of JGF. More clinically evidence-based research on JGF might be required in the future. Thereby, it may provide JGF as a choice for integrated Chinese and Western medicine toward COVID-19 and elevate the quality of treatment.
參考文獻
延伸閱讀
- 吳家雯（2005）。全民健康保險研究資料庫HMG-CoA Reductase Inhibitors處方型態及用藥安全性分析：自藥品交互作用觀點探討〔碩士論文，國立臺灣大學〕。華藝線上圖書館。https://doi.org/10.6342/NTU.2005.02195
- 譚延輝（2012）。高診次民眾藥事居家照護之成效。長期照護雜誌，16(2)，135-142。https://doi.org/10.6317/LTC.201209_16(2).0003
- 程維德、曾宣靜、李政育、廖炎智（2022）。育生中醫學派對COVID-19綜合症、疫苗副作用及後遺症治療病例的思考。中國鍼灸學雜誌，10(1)，186-205。https://doi.org/10.6528/CAMS.202212_10(1).0011
- 張淳淇、林曉蔓、林立偉、吳龍源（2022）。Analysis of the Regularity of Traditional Chinese Medicines Used in the Clinical Treatment of Women's Emotional Diseases-Taking Fu Qingzhu's Gynecology as an Example。中醫藥研究論叢，25(2)，17-33。https://doi.org/10.6516/TJTCM.202206_25(2).0002
- 陳緋娜、李珮端、謝慶良、林正介、江秀梅、林香汶、朱和翔、蔡文正、侯鈺琪、洪寶蓮（2008）。Survey on Adult Behavior and Medication of Chinese and Western Medicine-Based on the Outpatients of a Medical Center in Mid-Taiwan。中西整合醫學雜誌，10(2)，1-14。https://doi.org/10.29613/JICWM.200812.0001